Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded vaginal gel containing ascorbic acid, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing ascorbic acid are listed in injection form, all for intravenous use. It is also a component of FDA-approved kits.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Ascorbic acid (vitamin C) is a water-soluble vitamin and antioxidant that compounding pharmacies prepare as sterile injections and oral forms by prescription.
Ascorbic acid is vitamin C, an essential water-soluble vitamin that humans cannot make. It is a cofactor for enzymes that build collagen, carnitine and catecholamines, and an antioxidant that protects lipids, proteins and nucleic acids; it also improves iron absorption from plant foods. Oral vitamin C is sold over the counter as tablets, chewables, gummies, drops and powders. The FDA-approved prescription products are Ascor (ascorbic acid injection) and its approved generic equivalents, approved for short-term treatment of scurvy in adults and children 5 months and older when oral administration is not possible, insufficient or contraindicated; it is not indicated for vitamin C deficiency without signs of scurvy. A prescriber may order ascorbic acid compounded when a patient needs a preservative-free sterile preparation, a specific concentration, or a combination not manufactured. Compounded ascorbic acid preparations are not FDA-approved and require a prescription.
Ascor carries no boxed warning and lists no contraindications. Its warnings: oxalate kidney damage and kidney stones have been reported with prolonged high doses, with greater risk in kidney disease, prior oxalate stones, older adults and children under 2; hemolysis (red cell breakdown) has occurred in people with G6PD deficiency; and ascorbic acid can interfere with lab tests based on oxidation-reduction reactions, including glucose tests, for about 24 hours after an infusion. It may reduce the activity of several antibiotics (erythromycin, kanamycin, streptomycin, doxycycline, lincomycin), lowers amphetamine and fluphenazine levels by acidifying urine, and has interfered with warfarin in case reports. The label advises following the Recommended Dietary Allowance in pregnancy and nursing. Vitamin C is a normal part of breast milk, and maternal supplementation raises milk levels without reaching a level of concern. Rapid intravenous administration can cause faintness, nausea, flushing and headache; infusion-site pain is most common. Oral vitamin C can cause diarrhea, heartburn and gas. For flank pain or blood in the urine, talk to your prescriber or pharmacist.
Ascorbic acid is a cofactor in collagen hydroxylation, carnitine and catecholamine synthesis and gene regulation, and a reducing agent that scavenges reactive oxygen species; the exact mechanism in scurvy is restoration of the body pool. Oral absorption is saturable, about 85 percent at low intake and falling as intake rises; the body pool is limited and excess is not stored. It distributes widely with high concentrations in liver, leukocytes, platelets and lens, crosses the placenta and enters milk. Renal excretion rises steeply once plasma exceeds a renal threshold; a major metabolic route is conversion to urinary oxalate. Intravenous half-life was about 7.4 hours in a small study. The labeled indication (Ascor) is short-term treatment of scurvy when oral therapy is not possible, insufficient or contraindicated. Prescribers have ordered compounded sterile ascorbic acid for intravenous or intramuscular use when enteral absorption is impaired or in critical illness, which StatPearls describes. Dosing is per prescriber. Monitor renal function and urinary oxalate with high-dose or prolonged use and hemoglobin in G6PD deficiency, and schedule redox-based labs at least 24 hours after infusion. Keep intake below the tolerable upper level in renal impairment and iron-overload states. Ascorbic acid is not a controlled substance.
Wash your hands. Fill the applicator to the mark on your label, or use a prefilled applicator. Lie on your back with knees bent, insert the applicator gently as far as is comfortable, and push the plunger slowly until it stops. Remove the applicator; wash a reusable one with mild soap and water or discard a single-use one. Bedtime use is common. Wash your hands afterward.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, keep from freezing, keep out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert/apply intravaginally
